Logo

A Review and Comparison of Frameworks used in Behavioral Intervention Development Research - Shared screen with speaker view
Francis Keefe
26:22
Also, please send comments or questions to us via the chat function
Ashley Phillips
28:34
It seems that she is moving forward, but slides are not
Vanessa Burshnic
29:07
Agreed
Francis Keefe
30:24
Thanks to you both for letting us know..
t.oneil-pirozzi
43:36
Can/how often are Stage 1 & Stage 2 research combined?
kglanz
44:44
The Onken et al Stage Model is very parallel to the translational research model used in CTSA's, in cancer research (for many years - Greenwald et al.), and so on. Do you (or does Lisa et al.) see it as the behavioral science/change adaptation of those models?
Janet Prvu Bettger
45:38
Thanks for joining us Dr. Onken
Cristina Colon-Semenza
56:49
So this target is then a mediator on the causal pathway?
kglanz
01:01:48
Can you explain how you differentiate "theory" vs "model"? What makes something a theory vs model - since the terms are often used interchangeably?
Glenna Brewster
01:12:18
Do we know what is causing that sound?
Glenna Brewster
01:12:57
Nevermind.
Lavanya Vasudevan, Ph.D.
01:14:34
When we are considering these different frameworks, on what factors should we base the selection of one framework over another?
Megan Shepherd-Banigan
01:16:14
Do intervention development models address the idea that people respond differently to interventions (i.e. heterogenous treatment effects)? If not, do you have any suggestions for how to take that into consideration when we develop and test interventions?
Katherine Hall
01:25:00
Interesting question, Megan. I would think heterogeneity of treatment effects is better defined in the analytic model (vs. intervention development models). Thinking sub-group analyses to test impactful mediating factors etc., but this predicated on a large and diverse patient sample by which to appropriately look at this heterogeneity across groups and clinical characteristics. Would be curious what you and others think.
Jennifer Gierisch
01:26:29
That is my sense, Katherine, and what I messaged to MSB. Speaks to cultural adaptation and tailoring
Megan Shepherd-Banigan
01:32:41
That makes sense and I agree with the need for large and diverse samples and then plan to do sub-group analyses. I wonder whether some preliminary work during early stages can start to get at this because sometimes we don't know/can't anticipate which characteristics will affect treatment. This has been a great presentation--thank you!
Katherine Hall
01:33:57
Agreed!!
Jennifer Gierisch
01:35:40
This has been a great talk! Thanks for the opportunity to grow and learn.
Kelly
01:35:55
Will the ppt file be shared to the attendees?
Jessie Byrd, M.Ed.
01:36:22
Slides and recording will be shared with everyone. Thanks for asking
Kelly
01:37:15
Great. Thank you.
dladdu
01:38:22
Thank you so much! this was fantastic
Emily Kringle
01:38:31
Thank you! This was outstanding.
Dr Charles Wood
01:39:27
Are there any broad differences in behavior change when the behavior hasn't begun yet (i.e. preventing behaviors from developing)? In pediatrics, we are often working on avoiding developing detrimental feeding behaviors. Are there specific models that address prevention?
Shara Reihani
01:46:53
Thank you for the presentation.
Tolulope Oyesanya
01:47:11
Thank you Dr. Czajkowksi!
Jennifer Plumb Vilardaga
01:47:18
This was fantastic, thank you thank you!